SMFM Clinical Practice Guidelines Activity Restriction in Pregnancy Society of Maternal Fetal Medicine with the assistance of Erin Habecker, MD, and Anthony.

Slides:



Advertisements
Similar presentations
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Advertisements

Intrapartum Nursing Management of Preterm Labor
Umbilical cord clamping in term deliveries: the RCOG perspective Dr Anna David Reader and Consultant in Obstetrics and Maternal Fetal Medicine UCL Institute.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
بسم الله الرّحمن الرّحیم Hypertension in pregnancy R.Mohammadjafari.MD.Gynecologist.
Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.
Short Interpregnancy Spacing in Utah Lois Bloebaum MPA,BSN, Manager Reproductive Health Program Laurie Baksh MPH, PRAMS Data Manager Joanne McGarry BS,
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Elective Cesarean Delivery, Neonatal Intensive Care Unit Admission, and Neonatal Respiratory Distress 楊明智.
DR. HAZEM AL-MANDEEL OB/GYN ROTATION-COURSE 481 Multiple Pregnancy.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Underweight pregnant women in low risk populations: Does a low BMI (
William Goodnight, MD, MSCR Assistant Professor Division of Maternal Fetal Medicine UNC Chapel Hill School of Medicine.
SMFM Clinical Practice Guidelines Doppler assessment of the fetus with intrauterine growth restriction Society of Maternal Fetal Medicine with the Assistance.
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
SMFM Clinical Practice Guidelines
The Post-Partum Visit Re-Design Jeanne A. Conry, MD, PhD Chair, ACOG District IX.
SMFM Clinical Practice Guidelines
SMFM/ACOG Obstetric Care Consensus
GEORGIA HOSPITAL ENGAGEMENT NETWORK (GHEN)
SMFM Clinical Practice Guidelines Assessing nutritional needs in pregnant patients with prior bariatric surgery Society of Maternal Fetal Medicine with.
Medical Coding II Seminar 6.
Cook Island Presentation PSRH Conference Samoa Dr. May.
Max Brinsmead MB BS PhD May Definition and Incidence  Prolonged pregnancy is defined as that proceeding beyond 42 weeks gestation  In the absence.
“MENTAL HEALTH LITERACY AND POSTPARTUM DEPRESSION: A QUALITATIVE DESCRIPTION OF VIEWS OF LOWER INCOME WOMEN” – GUY (2014) -Jasmine R.
SMFM Clinical Practice Guidelines Isolated fetal choroid plexus cysts Society of Maternal Fetal Medicine with the assistance of Karin M. Fuchs MD Published.
Christopher R. Graber, MD Salina Women’s Clinic Mar 3, 2010.
Preterm Labor 早 产 林建华. epidemiology Labor and delivery between 28 – weeks Labor and delivery between 28 – weeks 5%-10% 5%-10% be the leading.
SMFM Clinical Practice Guidelines Tdap Vaccination in pregnancy Society of Maternal Fetal Medicine with the assistance of Neil Silverman, MD Published.
Preterm Birth Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
SMFM Consult Series Advanced maternal age and the risk of antepartum stillbirth Society of Maternal Fetal Medicine with the assistance of Amanda Stone,
POSTTERM PREGNANCY: THE IMPACT ON MATERNAL AND FETAL OUTCOME Dr. Hussein. S. Qublan- Al-Hammad Jordanian Board in Obstet &Gynecology European Board in.
SMFM Clinical Practice Guidelines Risks of chorionic villus sampling and amniocentesis Society of Maternal Fetal Medicine with the assistance of Joanne.
P REMATURE D ELIVERY Trends from a West Texas Hospital Edwin E. Henslee MD, PGY-2 Selman I. Welt MD.
Abnormal second – stage labor.  Multiple short term & long term maternal & neonatal outcomes should be considered.
SMFM Consult Series Peridontal disease and preterm birth Society of Maternal Fetal Medicine with the assistance of Kim Bogess, MD Published in Contemporary.
Preterm Labor & Preterm Birth Family Medicine Specialist CME Vientiane, Lao PDR December 10 – 12, 2008.
SMFM Consult Series Management of cesarean delivery in the morbidly obese woman Society of Maternal Fetal Medicine with the assistance of Donna Johnson,
SMFM Clinical Practice Guidelines
Preterm Labor Williams CH.36. Preterm Birth Death, severe neonatal morbidities Common before 26 weeks Universal before 24 weeks.
Cervical length & Prediction of preterm labor Current Opinion in Obstetrics & Gynecology 19, April 2007 p.191~195 부산백병원 산부인과 R2 정은정.
MANAGEMENT OF PRETERM LABOR WITH INTACT MEMBRANES by Dr. Elmizadeh.
SMFM Clinical Consult Series
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
Mei-Chun LU, Song-Shan HUANG, Yuan-Horng YAN, Panchalli WANG, Yueh-Han HSU, Wei CHEN Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi,
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
25th European Board & College of Obstetrics and Gynecology
UOG Journal Club: March 2017
Vincenzo Berghella, MD; Tracy Manuck, MD
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
UOG Journal Club: August 2017
Obstetrical and perinatal complications of twin pregnancies:
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
Inonu University, Turgut Ozal Medical Centre
Hypothyroidism during pregnancy
Vital statistics in obstetrics.
SMFM Clinical Practice Guidelines
UOG Journal Club: March 2017
Intrauterine growth restriction: A new concept in antenatal management
Jeffrey A. Kuller, MD; Sean C. Blackwell, MD
The Utilization of Sequential Compression Devices Among Pregnant Women
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study David B. Nelson, MD; Donald D. McIntire,
Induction of labor (IOL)
Chantal Nelson BORN Annual Conference April 25, 2017
Pregnancy at Risk: Gestational Conditions
Presentation transcript:

SMFM Clinical Practice Guidelines Activity Restriction in Pregnancy Society of Maternal Fetal Medicine with the assistance of Erin Habecker, MD, and Anthony Sciscione, DO Published in Contemporary OB/GYN / August 2014

What is restriction of activity in pregnancy?  Restriction of activity, once used often for pregnant and postpartum women, is currently a proposal for a number of potential pregnancy morbidities. These include, but are not limited to:  Preterm contractions, arrested preterm labor, short cervix, preterm premature rupture of membranes (PPROM), elevated blood pressure, preeclampsia, intrauterine growth restriction (IUGR), placenta previa, threatened abortion, and multiple gestation.  The terms “bed rest” and “activity restriction” are often used synonymously, but can differ to a great extent in clinical practice.  Most antepartum inpatients undergo “bed rest” as defined by Fox et al, that is, limited ambulation of not more than 1 to 2 hours per day with bathroom use and bathing permitted.  In general, the term “activity restriction” is preferable to “bed rest.” There is variability in when, why, and to what extent activity restriction is assigned, with varying degrees of stringency. Consistency is important for both clinical and research purposes.

How common is it ?  Survey data from several studies indicate that the prescription of activity restriction is a common practice among both ob/gyns and maternal-fetal medicine subspecialists, despite the fact that many obstetric providers surveyed did not expect the practice to prevent adverse outcomes.

What are the risks associated with activity restriction?  The practice of activity restriction was called into question when the physiologic consequences of prolonged, strict activity restriction were first documented in the 1950s.  Lack of weightbearing activity results in loss of muscle mass, bone mass, plasma volume, and cardiovascular capacity in a phenomenon now known as “deconditioning.”  Physiologic changes can be clinically significant after only a few days of immobility. Changes such as those described later are well documented in nonpregnant patients placed on activity restriction, and have been demonstrated to varying degrees in pregnant patients.  High-quality data on the full extent of physiologic changes in pregnant women placed on activity restriction, however, are lacking.

What are the risks associated with activity restriction?  Nonambulatory patients have an increased risk of deep venous thrombosis (DVT).  Pregnant women are known to be at increased risk of DVT and other thrombotic morbidities such as pulmonary embolism (PE), with an incidence rate of 0.8 to 1.72 per 1000 pregnancies (as a comparison, the incidence rate in the general population is 0.1 to 0.5 per 1000 per year).  Kovacevich and colleagues reported a DVT rate of 15.6/1000 in pregnant women placed on bed rest, versus a rate of 0.8/1000 in a control group of pregnant women who were not placed on bed rest (P <0.0015).  Although another retrospective cohort study failed to associate bed rest with increased rates of DVT or PE, a third found an elevated risk of PE in patients on bed rest.  Overall, the data demonstrate an increased risk of thromboembolic events in patients placed on activity restriction

What are the risks associated with activity restriction?  Lack of compression force on weightbearing bones, increased bone turnover due to altered maternal calcium homeostasis, and maternal hormonal changes are thought to place pregnant patients at greater risk of accelerated bone loss. Indeed, several studies have found not only that women placed on bed rest are at higher risk of bone mineral density loss, but also that markers of bone turnover are significantly higher in these women at 34 weeks’ gestation.  Muscle atrophy from deconditioning has been documented in antepartum women placed on bed rest through an increased time to re-oxygenation after exercise in the gastrocnemius muscle; maternal complaints of soreness and difficulty with mobility were also frequently reported in this group.

What are the risks associated with activity restriction?  Evidence suggests that restriction of activity is associated with a higher rate of gestational diabetes mellitus (GDM) among women admitted to the hospital for antepartum management of pregnancy-related complications. One retrospective study found that the risk of development of GDM was increased 1.04 times for every day a pregnant woman remained on the inpatient unit.  More study is necessary in this area, but elevated blood glucose levels have been well-documented in nonpregnant patients placed on activity restrictions.The concern that pregnant women on activity restriction may be at higher risk of development of GDM is biologically plausible.  Along with the potential physical harms to the woman associated with activity restriction in pregnancy, there is an increased incidence of lower birth weights, maternal anxiety and depression, loss of income, and adverse psychological effects on the family.

What are the benefits associated with activity restriction in pregnancy for prevention of preterm birth?  Only one trial has met criteria for a Cochrane review addressing bed rest in singleton pregnancies for the prevention of preterm birth. This study randomly assigned women at risk of preterm birth to bed rest versus no treatment or a placebo intervention.  No differences were found between the 2 groups with regards to preterm birth rate before 37 weeks’ gestation (7.9% in the intervention group vs 8.5% in the control group, RR 0.92, 95% CI, 0.62–1.37)  Elliott and colleagues conducted a randomized controlled trial in which women with preterm labor (≥ 6 contractions per hour at time of admission) and a negative fetal fibronectin test were assigned to activity restriction or normal activity at time of hospital discharge. No differences were seen in preterm delivery rates between the 2 groups (44 vs 39%, P =0.478)

What are the benefits associated with activity restriction in pregnancy for prevention of preterm birth?  Grobman and colleagues found that preterm birth at less than 37 weeks’ gestation appears to be more common when patients are placed on any kind of activity restriction, whether pelvic, work or non-work rest, in both inpatient and outpatient settings.  “Any activity restriction” was defined as being placed on any type of rest. Their study involved nulliparous women with incidentally diagnosed short cervix (<30 mm by mid- trimester scan) randomized to treatment with 17-α hydroxyprogesterone caproate or placebo.  After controlling for potential compounding factors, they found an increase in risk of delivery before 37 weeks’ gestation (OR 2.37; 95% CI, 1.60–3.53) as well as an increased risk before 34 weeks’ gestation among women placed on activity restriction.  These data are consistent with a retrospective cohort study of women with cervical length < 25 mm and showed a correlation between hospitalization and cervical shortening (P =0.005)

What are the benefits associated with activity restriction in pregnancy for prevention of preterm birth?  No study to date has identified improvements in neonatal outcomes in women with short cervix or threatened preterm labor who undergo activity restriction.  However, there is evidence of higher rates of neonatal complications, including lower birth weight and earlier gestational age at delivery, and a higher likelihood of development of motion sickness and allergies later in life

Are there other pregnancy conditions that may potentially benefit from activity restriction?  The most common reasons for antepartum hospital admission and triggers for an obstetric provider’s recommendation of activity restriction:  Hypertensive disorders of pregnancy  PPROM  Multiple gestation  Impaired fetal growth are among

Conditions that may potentially benefit from activity restriction: HTN  The potential for decrease in systolic blood pressure and subsequent, although theoretical, improvement in placental perfusion associated with activity restriction could potentially outweigh the risks of DVT and deconditioning.  However, the only randomized controlled trials showing improvement in outcomes compared women with preeclampsia who were assigned to bed rest with women who underwent immediate delivery, which does not allow independent analysis of activity restriction as an intervention.  A 2006 Cochrane review on the subject of prevention of preeclampsia in women at moderate risk of developing the disorder (hypertension after 26 weeks’ gestation, with or without proteinuria) concluded that modest restriction of activity, with 4 to 6 hours per day of rest, may be associated with reduced risk of preeclampsia.  Small sample size and uncertain study quality prevented generalization of these data and the authors concluded that there was insufficient evidence to recommend the practice.

Conditions that may potentially benefit from activity restriction: PPROM  Women with PPROM are currently managed with inpatient admission to be close to neonatal and obstetrical services due to the unpredictability of labor and the potential for rapid delivery, development of infection, or fetal compromise.  Often these women are also placed on activity restriction or bed rest in an effort to increase latency until delivery and to prevent umbilical cord prolapse.  However, there are no studies to date examining the effect, if any, on pregnancy outcomes.

Conditions that may potentially benefit from activity restriction: Multiple Gestations  Women with multiple gestations are at an increased risk of preterm birth.  Routine inpatient bed rest was once offered routinely to such patients in middle to late pregnancy.  Seven randomized clinical trials have been conducted that included 713 women assigned to routine inpatient bed rest versus hospitalization only if complications developed.  These trials did not demonstrate any reduction in preterm birth or perinatal mortality.  The only detectable benefit was a decrease in the number of neonates born with birth weight < 2500 g, suggesting that bed rest may be a benefit to fetal growth in this population.  Few studies have examined less-commonly-reported maternal outcomes in women with multiple gestations who were placed on activity restriction, such as weight gain and indicators of mental health status. Maloni and colleagues found that maternal stressors, symptomatic side effects, and depressive symptoms all increased, while maternal weight gain was suboptimal, in patients placed on hospital bed rest.

Conditions that may potentially benefit from activity restriction: IUGR  IUGR is often attributed to placental insufficiency, and activity restriction and/or bed rest is often prescribed in an effort to improve placental perfusion.  However, a Cochrane review found only a single randomized controlled trial that allocated women with growth-restricted fetuses to either bed rest in the hospital or work restriction at home (no subjects were allocated to normal activity).  No differences were found with regard to infant birth weight, Apgar scores, cord pH, or operative delivery rate. The reviewers noted that the study’s small sample size (N= 101) may have been insufficient to unmask differences between groups, but nonetheless noted that they were unable to recommend the practice of hospital bed rest for growth restriction.

What are the current recommendations from professional societies?  The American College of Obstetricians and Gynecologists states that bed rest has not been shown to be effective for the prevention of preterm birth and should not be routinely recommended (Level B evidence).  The Society of Obstetricians and Gynaecologists of Canada states that increased rest at home in the third trimester (Level I-C evidence) or reduction of workload and stress (Level III-C evidence) may be useful for women at risk of developing preeclampsia.  Strict bed rest in the hospital for women diagnosed with preeclampsia is not recommended (Level I-D evidence).  The National Collaborating Centre for Women’s and Children’s Health, in collaboration with the Royal College of Obstetricians and Gynaecologists, states that bed rest has not been shown to be of benefit and should not be offered to women with gestational hypertension or preeclampsia.  No other national recommendations exist regarding the use of activity restriction or bed rest in pregnancy.

Summary  The practice of routine use of activity restriction or bed rest during pregnancy to improve maternal or neonatal outcomes is not supported by available data.  There are potential risks specifically associated with activity restriction and bed rest.  A recent commentary has argued that routine use of these interventions should be restricted to formal clinical trials.  We recommend against the routine use of activity restriction or bed rest during pregnancy for any indication (Grade 1B, strong recommendation with moderate quality of evidence.

 The practice of medicine continues to evolve, and individual circumstances will vary. This opinion reflects information available at the time of its submission for publication and is neither designed nor intended to establish an exclusive standard of perinatal care. This presentation is not expected to reflect the opinions of all members of the Society for Maternal-Fetal Medicine.  These slides are for personal, non- commercial and educational use only Disclaimer

Disclosures  This opinion was developed by the Publications Committee of the Society for Maternal Fetal Medicine with the assistance of Stanley M. Berry, MD, Joanne Stone, MD, Mary Norton, MD, Donna Johnson, MD, and Vincenzo Berghella, MD, and was approved by the executive committee of the society on March 11, Dr Berghella and each member of the publications committee (Vincenzo Berghella, MD [chair], Sean Blackwell, MD [vice-chair], Brenna Anderson, MD, Suneet P. Chauhan, MD, Jodi Dashe, MD, Cynthia Gyamfi-Bannerman, MD, Donna Johnson, MD, Sarah Little, MD, Kate Menard, MD, Mary Norton, MD, George Saade, MD, Neil Silverman, MD, Hyagriv Simhan, MD, Joanne Stone, MD, Alan Tita, MD, Michael Varner, MD) have submitted a conflict of interest disclosure delineating personal, professional, and/or business interests that might be perceived as a real or potential conflict of interest in relation to this publication.